Basic Information
| LncRNA/CircRNA Name | LINC00612 |
| Synonyms | NA |
| Region | GRCh38_12:9055586-9065070 |
| Ensemble | ENSG00000214851 |
| Refseq | NR_034140 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | apoptosis | Drug | ||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | bladder cancer |
| ICD-0-3 | C67 |
| Methods | qPCR, Luciferase reporter assay, Western blot, RNAi, RIP |
| Sample | BC tissues,cell line(5637, UMUC3,T24,SV-HUC-1,HEK-293) |
| Expression Pattern | up-regulated |
| Function Description | LINC00612 was upregulated in BC tissues and cell lines. |
| Pubmed ID | 30940184 |
| Year | 2019 |
| Title | LINC00612 enhances the proliferation and invasion ability of bladder cancer cells as ceRNA by sponging miR-590 to elevate expression of PHF14. |
External Links
| Links for LINC00612 | GenBank HGNC NONCODE |
| Links for bladder cancer | OMIM COSMIC |